Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0114CP (levocetirizine) in perennial allergic rhinitis
2007-003572-19Phase 3Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levocetirizine in perennial rhinitis (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Instantaneous nasal symptom score change over 6 weeks. Started Oct 2007; status: terminated.
02
Drugs
levocetirizine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2007-003572-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003572-19.